Physician profile
Raulee Morello
NPI 1073961751
$921.75
in general payments reported to CMS, 2019-2025
22 companies · $497 in 2025
The $497 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.77 · 2023: $264 · 2024: $142 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $195.33 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.80 | 2023-2025 | Fruzaqla, Ninlaro |
| Incyte Corporation | $72.17 | 2024-2025 | Monjuvi |
| Astrazeneca Pharmaceuticals LP | $64.03 | 2023-2025 | Lynparza |
| Merck Sharp & Dohme LLC | $58.03 | 2024-2025 | Keytruda, Lynparza |
| Daiichi Sankyo INC. | $51.99 | 2025 | Enhertu |
| Sobi, INC | $41.79 | 2024-2025 | |
| Pharmacosmos Therapeutics INC. | $35.86 | 2024-2025 | Monoferric |
| Janssen Biotech, INC. | $34.98 | 2025 | Rybrevant |
| Ethicon US, LLC | $28.45 | 2025 | Vistaseal |
| Regeneron Healthcare Solutions, INC. | $26.91 | 2025 | Libtayo |
| Foundation Medicine, INC. | $26.00 | 2023 | |
| Servier Pharmaceuticals LLC | $24.76 | 2023 | |
| Genzyme Corporation | $24.64 | 2025 | |
| Cardinal Health 414 LLC | $23.37 | 2025 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fennec Pharmaceuticals, INC. | $21.21 | 2025 | Fyarro |
| Iovance Biotherapeutics, INC. | $21.19 | 2025 | Amtagvi |
| Merit Medical Systems INC | $20.12 | 2025 | Savi Scout, Savi Brachy |
| Novartis Pharmaceuticals Corporation | $19.93 | 2024 | |
| Medtronic USA, INC. | $18.77 | 2020 | |
| Recordati_rare_diseases_inc. | $16.97 | 2025 | Sylvant |
| Karyopharm Therapeutics INC. | $15.45 | 2025 | Xpovio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raulee Morello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.